Neuroimaging in Multiple Sclerosis

International Review of Neurobiology

Volumn 67, Issue , 2005, Pages 165-201

  Minagar, Alireza ^a   Gonzalez Toledo, Eduardo ^a   Pinkston, James ^a   Jaffe, Stephen L ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; HUMAN; MULTIPLE SCLEROSIS; PATHOLOGY; REVIEW;

BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; HUMANS; MULTIPLE SCLEROSIS;

EID: 33645945004     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(05)67006-7     Document Type: Review

References (84)

1. Arnold D.L., Matthews P.M., Francis G.S., O'Connor J., and Antel J.P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31 (1992) 235-241
2. Asghar-Ali A.A., Taber K.H., Hurley R.A., and Hayman L.A. Pure neuropsychiatric presentation of multiple sclerosis. Am. J. Psychiatry 161 (2004) 226-231
3. Audoin B., Ibarrola D., Ranjeva J.P., Confort-Gouny S., Malikova I., Ali-Cherif A., Pelletier J., and Cozzone P. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum. Brain Mapp. 20 (2003) 51-58
4. Bagert B., Camplair P., and Bourdette D. Cognitive dysfunction in multiple sclerosis: Natural history, pathophysiology and management. CNS. Drugs 16 (2002) 445-455
5. Bakshi R., Miletich R.S., Kinkel P.R., Emmet M.L., and Kinkel W.R. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging 8 (1998) 228-234
6. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Heppner F., Price G., Wegner F., Giovannoni G., Miller D.H., Perkin G.D., Smith T., Hewson A.K., Bydder G., Kreutzberg G.W., Jones T., Cuzner M.L., and Myers R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 Pt 11 (2000) 2321-2337
7. Benedict R.H., Bakshi R., Simon J.H., Priore R., Miller C., and Munschauer F. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J. Neuropsychiatry Clin. Neurosci. 14 (2002) 44-51
8. Benedict R.H., Carone D.A., and Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J. Neuroimaging 14 3 Suppl (2004) 36S-45S
9. Benedict R.H., Weinstock-Guttman B., Fishman I., Sharma J., Tjoa C.W., and Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch. Neurol. 61 (2004) 226-230
10. Berg D., Maurer M., Warmuth-Metz M., Rieckmann P., and Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch. Neurol. 57 (2000) 1289-1292
11. Bermel R.A., Bakshi R., Tjoa C., Puli S.R., and Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch. Neurol. 59 (2002) 275-280
12. Blinkenberg M., Rune K., Jonsson A., Holm S., Jensen C.V., Paulson O.B., and Sorensen P.S. Cerebral metabolism in a case of multiple sclerosis with acute mental disorder. Acta Neurol. Scand. 94 (1996) 310-313
13. Blinkenberg M., Jensen C.V., Holm S., Paulson O.B., and Sorensen P.S. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 53 (1999) 149-153
14. Blinkenberg M., Rune K., Jensen C.V., Ravnborg M., Kyllingsbaek S., Holm S., Paulson O.B., and Sorensen P.S. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 54 (2000) 558-564
15. Calabresi P.A., Fields N.S., Farnon E.C., Frank J.A., Bash C.N., Kawanashi T., Maloni H., Jacobson S., and McFarland H.F. ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: Correlation with MRI lesions. J. Neuroimmunol. 85 (1998) 212-219
16. Castriota-Scandenberg A., Fasano F., Hagberg G., Nocentini U., Filippi M., and Caltagirone C. Coefficient Dav is more sensitive than fractional anisotropy in monitoring progression or irreversible tissue damage in focal non-active multiple sclerosis lesions. Am. J. Neuroradiol. 24 (2003) 663-670
17. Charil A., Zijdenbos A.P., Taylor J., Boelman C., Worsley K.J., Evans A.C., and Dagher A. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: Application to 452 patient data sets. Neuroimage 19 (2003) 532-544
18. Christodoulou C., Krupp L.B., Liang Z., Huang W., Melville P., Roque C., Scherl W.F., Morgan T., MacAllister W.S., Li L., Tudorica L.A., Li X., Roche P., and Peyster R. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 60 (2003) 1793-1798
19. Comi G., Rovaris M., Leocani L., Martinelli V., and Filippi M. Clinical and MRI assessment of brain damage in MS. Neurol. Sci. 22 Suppl. 2 (2001) S123-S127
20. Debruyne J.C., Van Laere K.J., Versijpt J., De Vos F., Eng J.K., Strijckmans K., Santens P., Achten E., Slegers G., Korf J., Dierckx R.A., and De Reuck J.L. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol. Belg. 102 (2002) 127-135
21. Debruyne J.C., Versijpt J., Van Laere K.J., De Vos F., Keppens J., Strijckmans K., Achten E., Slegers G., Dierckx R.A., Korf J., and De Reuck J.L. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur. J. Neurol. 10 (2003) 257-264
22. DeSousa E.A., Albert R.H., and Kalman B. Cognitive impairments in multiple sclerosis: A review. Am. J. Alzheimer's Dis. Other Demen. 17 (2002) 23-29
23. De Stefano N., Matthews P.M., and Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34 (1995) 721-727
24. Dousset V., Grossman R.I., Ramer K.N., Schnall M.D., Young L.H., Gonzalez-Scarano F., Lavi E., and Cohen J.A. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology 182 (1992) 483-491 [Erratum in:Radiology183, 878.]
25. Dousset V., Gayou A., Brochet B., and Caille J.M. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 51 (1998) 1150-1155
26. Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K., McDonald W.I., McFarland H.F., Paty D.W., Simon J.H., Wolinsky J.S., and Miller D.H. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 11 (1999) 448-456
27. Filippi M., Rocca M.A., Mezzapesa D.M., Falini A., Colombo B., Scotti G., and Comi G. A functional MRI study of cortical activations associated with object manipulation in patients with MS. Neuroimage 21 (2004) 1147-1154
28. Fischer J. Assessment of neuropsychological function in multiple sclerosis. In: Cohen J. (Ed). "Multiple sclerosis therapeutics" (2003), Martin Dunitz Ltd, Inc., New York 37-59
29. Frank J.A., Stone L.A., Smith M.E., Albert P.S., Maloni H., and McFarland H.F. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: Implications for treatment trials. Ann. Neurol. 36 (1994) S86-S90
30. Gadea M., Martinez-Bisbal M.C., Marti-Bonmati L., Espert R., Casanova B., Coret F., and Celda B. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. Brain 127 Pt 1 (2004) 89-98
31. Gandelman-Marton R., Rabey J.M., and Flechter S. Periodic lateralized epileptiform discharges in multiple sclerosis: A case report. J. Clin. Neurophysiol. 20 (2003) 117-121
32. Goodkin D.E., Rooney W.D., Sloan R., Bacchetti P., Gee L., Vermathen M., Waubant E., Abundo M., Majumdar S., Nelson S., and Weiner M.W. A serial study of new MS lesions and the white matter from which they arise. Neurology 51 (1998) 1689-1697
33. Hartung H.P., Reiners K., Archelos J.J., Reiners K., Archelos J.J., Michels M., Seeldrayers P., Heidenreich F., Pflughaupt K.W., and Toyka K.V. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging. Ann. Neurol. 38 (1995) 186-193
34. Iniguez C., Campos R., and Larrode P. Steroid treatment of acute psychosis associated with multiple sclerosis. Rev. Neurol. 31 (2000) 841-844
35. Janardhan V., and Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch. Neurol. 57 (2000) 1485-1491
36. Jansen H.M., Willemsen A.T., Sinnige L.G., Paans A.M., Hew J.M., Franssen E.J., Zorgdrager A.M., Pruim J., Minderhoud J.M., and Korf J. Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis. J. Neurol. Sci. 132 (1995) 139-145
37. Jansen H.M., Decoo D., and Minderhoud J.M. Co-registration of PET and MRI in different courses of MS using Cobalt-55 as a Calcium-tracer. Acta Neurol. Belg. 97 (1997) 178-182
38. Jy W., Minagar A., Jimenez J.J., Sheremata W.A., Mauro L.M., Horstman L.L., Bidot C., and Ahn Y.S. Endothelial microparticles (EMP) bind and activate monocytes: Elevated EMP-monocyte conjugates in multiple sclerosis. Front. Biosci. 9 (2004) 3137-3144
39. Kappos L., Moeri D., and Radue E.W. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 353 (1999) 964-949.
40. Kermode A.G., Thompson A.J., and Tofts P. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113 Pt 5 (1990) 1477-1489
41. Khoury S.J., Guttmann C.R., and Orav E.J. Longitudinal MRI in multiple sclerosis: Correlation between disability and lesion burden. Neurology 44 (1994) 2120-2124
42. Khoury S.J., Orav E.J., Guttmann C.R., Kikinis R., Jolesz F.A., and Weiner H.L. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology 53 (1999) 758-764
43. Kimura H., Grossman R.I., Lenkinski R.E., and Gonzalez-Scarano F. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: Correlative findings of active versus irreversible plaque disease. AJNR. Am. J. Neuroradiol. 17 (1996) 1539-1547
44. Lowe M.J., Phillips M.D., Lurito J.T., Mattson D., Dzemidzic M., and Mathews V.P. Multiple sclerosis: Low-frequency temporal blood oxygen level-dependent fluctuations indicate reduced functional connectivity-initial results. Radiology 224 (2002) 184-192
45. Mainero C., Caramia F., and Pozzilli C. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 21 (2004) 858-867
46. Masdeu J.C., Moreira J., and Trasi S. The open ring. A new imaging sign in demyelinating disease. J. Neuroimaging 6 (1996) 104-107
47. Miller S.W., and Potsaid M.S. Focal brain scan abnormalities in multiple sclerosis. J. Nucl. Med. 15 (1974) 131-133
48. Minagar A., and Sheremata W.A. Glossopharyngeal neuralgia and MS. Neurology 54 (2000) 1368-1370
49. Minagar A., Sheremata W.A., and Tusa R.J. Perverted head-shaking nystagmus: A possible mechanism. Neurology 57 (2001) 887-889
50. Minagar A., Jy W., Jimenez J.J., Sheremata W.A., Mauro L.M., Mao W.W., Horstman L.L., and Ahn Y.S. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56 (2001) 1319-1324
51. Minagar A. Gray matter involvement in multiple sclerosis: A new window into pathogenesis. J. Neuroimaging 13 (2003) 291-292
52. Molyneux P.D., Filippi M., Barkhof F., Gasperini C., Yousry T.A., Truyen L., Lai H.M., Rocca M.A., Moseley I.F., and Miller D.H. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann. Neurol. 43 (1998) 332-339
53. Nauta J.J., Thompson A.J., Barkhof F., and Miller D.H. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs. J. Neurol. Sci. 122 (1994) 6-14
54. Oh J., Henry R.G., Genain C., Nelson S.J., and Pelletier D. Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1281-1286
55. Olivero W.C., Dulebohn S.C., and Lister J.R. The use of PET in evaluating patients with primary brain tumours: Is it useful?. J. Neurol. Neurosurg. Psychiatry 58 (1995) 250-252
56. Pan J.W., Krupp L.B., Elkins L.E., and Coyle P.K. Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Appl. Neuropsychology 8 (2001) 155-160
57. Pike G.B., De Stefano N., Narayanan S., Worsley K.J., Pelletier D., Francis G.S., Antel J.P., and Arnold D.L. Multiple sclerosis: Magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 215 (2000) 824-830
58. Piras M.R., Magnano I., Canu E.D., Paulus K.S., Satta W.M., Soddu A., Conti M., Achene A., Solinas G., and Aiello I. Longitudinal study of cognitive dysfunction in multiple sclerosis: Neuropsychological, neuroradiological, and neurophysiological findings. J. Neurol. Neurosurg. Psychiatry 74 (2003) 878-885
59. Rao S. Neuropsychology of multiple sclerosis. J. Clin. Experimental. Neuropsychology 8 (1986) 503-542
60. Rao S., Leo G., and Bernardin L. Cognitive dysfunction in multiple sclerosis: I frequency, patterns, and prediction. Neurology 41 (1991) 685-691
61. Rocca M.A., Mastronardo G., Rodegher M., Comi G., and Filippi M. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am. J. Neuroradiol. 20 (1999) 821-827
62. Roelcke U., Kappos L., Lechner-Scott J., Brunnschweiler H., Huber S., Ammann W., Plohmann A., Dellas S., Maguire R.P., Missimer J., Radu E.W., Steck A., and Leenders K.L. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48 (1997) 1566-1571
63. Rovaris M., and Filippi M. MRI correlates of cognitive dysfunction in multiple sclerosis patients. J. Neurovirol. 6 Suppl. 2 (2000) S172-S175
64. Rovaris M., Iannucci G., Falautano M., Possa F., Martinelli V., Comi G., and Filippi M. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: An exploratory study with diffusion tensor MR imaging. J. Neurolo. Sci. 195 (2002) 103-109
65. Sabatini U., Pozzilli C., Pantano P., Koudriavtseva T., Padovani A., Millefiorini E., Di Biasi C., Gualdi G.F., Salvetti M., and Lenzi G.L. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol. Psychiatry 39 (1996) 970-975
66. Santa Maria M.P., Benedict R.H., Bakshi R., Coad M.L., Wack D., Burkard R., Weinstock-Guttman B., Roberts S., and Lockwood A.H. Functional imaging during covert auditory attention in multiple sclerosis. J. Neurol. Sci. 15 (2004) 9-15
67. Santos A.C., Narayanan S., de Stefano N., Tartaglia M.C., Francis S.J., Arnaoutelis R., Caramanos Z., Antel J.P., Pike G.B., and Arnold D.L. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J. Neurol. 249 (2002) 662-668
68. Schiepers C., Van Hecke P., Vandenberghe R., Van Oostende S., Dupont P., Demaerel P., Bormans G., and Carton H. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult. Scler. 3 (1997) 8-17
69. Simon J.H., Jacobs L.D., Campion M., Wende K., Simonian N., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Alam J.J., Fischer J.S., Goodkin D.E., Granger C.V., Lajaunie M., Martens-Davidson A.L., Meyer M., Sheeder J., Choi K., Scherzinger A.L., Bartoszak D.M., Bourdette D.N., Braiman J., Brownscheidle C.M., and Whitham R.H. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann. Neurol. 43 (1998) 79-87
70. Sperling R.A., Guttmann C.R., and Hohol M.J. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: A longitudinal study. Arch. Neurol. 58 (2001) 115-121
71. Staffen W., Mair A., Zauner H., Unterrainer J., Niederhofer H., Kutzelnigg A., Ritter S., Golaszewski S., Iglseder B., and Ladurner G. Cognitive function and fMRI in patients with multiple Sclerosis: Evidence for compensatory cortical activation during an attention task. Brain 125 (2002) 1275-1282
72. Sweet L.H., Rao S.M., Primeau M., Mayer A.R., and Cohen R.A. Functional magnetic resonance imaging of working memory among multiple sclerosis patients. J. Neuroimaging 14 (2004) 150-157
73. Terada H., and Kamata N. Contribution of the combination of (201)Tl SPECT and (99m)T(c)O(4)(-) SPECT to the differential diagnosis of brain tumors and tumor-like lesions. A preliminary report. J. Neuroradiol. 30 (2003) 91-94
74. van Buchem M.A., Grossman R.I., Armstrong C., Polansky M., Miki Y., Heyning F.H., Boncoeur-Martel M.P., Wei L., Udupa J.K., Grossman M., Kolson D.L., and McGowan J.C. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 50 (1998) 1609-1617
75. van Buchem M.A., McGowan J.C., Kolson D.L., Polansky M., and Grossman R.I. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden. Magn. Reson. Med. 36 (1996) 632-636
76. van Waesberghe J.H., van Walderveen M.A., Castelijns J.A., Scheltens P., Lycklama A., Nijeholt G.J., Polman C.H., and Barkhof F. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am. J. Neuroradiol. 19 (1998) 675-683
77. Viñuela F.V., Fox A.J., Debrun G.M., Feasby T.E., and Ebers G.C. New perspectives in computed tomography of multiple sclerosis. AJR Am. J. Roentgenol. 139 (1982) 123-127
78. Wilms H., Claasen J., Rohl C., Sievers J., Deuschl G., and Lucius R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: Evidence from activated microglial cells in vitro. Neurobiol. Dis. 14 (2003) 417-424
79. Yousry I., Filippi M., Walther E., Gasperini C., Capra R., and Yousry T.A. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: Triple vs. single dose. Magn. Reson. Imaging 18 (2000) 1183-1186
80. Zivadinov R., and Bakshi R. Role of MRI in multiple sclerosis I: Inflammation and lesions. Front. Biosci. 9 (2004) 665-683
81. Zivadinov R., and Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging 14 Suppl. 3 (2004) S27-S35
82. Zivadinov R., De Masi R., Nasuelli D., Bragadin L.M., Ukmar M., Pozzi-Mucelli R.S., Grop A., Cazzato G., and Zorzon M. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 43 (2001) 272-278
83. Zivadinov R., Zorzon M., Locatelli L., Stival B., Monti F., Nasuelli D., Tommasi M.A., Bratina A., and Cazzato G. Sexual dysfunction in multiple sclerosis: A MRI, neurophysiological and urodynamic study. J. Neurol. Sci. 210 (2003) 73-76
84. Zorzon M., Zivadinov R., Locatelli L., Stival B., Nasuelli D., Bratina A., Bosco A., Tommasi M.A., Pozzi Mucelli R.S., Ukmar M., and Cazzato G. Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis. Mult. Scler. 9 (2003) 108-110